Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions
GVHDHematologic Neoplasms
Interventions
DRUG

Cyclophosphamide

Day 3 and day 4 following transplant. Dosing will be based on patients' actual weight up to 120% of ideal body weight, above which it will be based on adjusted ideal body weight (ideal weight plus 50% of the difference between ideal and actual weight).

DRUG

abatacept

Abatacept at a dose of 10mg/kg will be administered on days +5, +14 and +28, +56, +84, +112, +140, +168

DRUG

Methotrexate

standard of care Methotrexate 5 mg/m2 on Days 1, 3, 6 and 11

DRUG

Tacrolimus

Tacrolimus per institutional guidelines

Trial Locations (1)

92093

UC San Diego Moores Cancer Center, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Dimitrios Tzachanis, MD PhD

OTHER